Navigation Links
National Jewish Health Developing a Molecular Roadmap for Chronic Lung Diseases
Date:10/7/2009

National Jewish Health, University of Colorado Denver, University of Pittsburgh, Dana-Farber Cancer Institute and Boston University in joint NHLBI project

DENVER, Oct. 7 /PRNewswire-USNewswire/ -- Researchers at five research centers have been awarded an $11 million, two-year grant from the National Heart Lung and Blood Institute as part of the NIH Recovery Act that will allow a team of national scientists to delve deeply into the biology of two fatal lung diseases for which there are few therapeutic options. The multi-center Lung Genomics Research Consortium will use advanced genetic and molecular tools to characterize and better understand chronic obstructive pulmonary disease and pulmonary fibrosis, then share its discoveries with researchers around the world in a web-accessible data warehouse.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080711/DC27335LOGO)

"Our aim is create a genetic and molecular treasure trove for the research community to redefine these lung diseases precisely and unequivocally," said David Schwartz, MD, one of the lead researchers on the project and Director of The Center for Genes, Environment and Health at National Jewish Health. "The genetic, epigenetic, transcriptional, and phenotypic data we generate will provide an unprecedented window into the origins, dynamic biological features and unique presentations of these diseases. It will allow researchers to make fundamental discoveries that help identify individuals at risk for these diseases, diagnose them earlier, and develop more effective, personalized treatments."

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States. The incidence of pulmonary fibrosis has doubled over the past decade, and now kills about 40,000 Americans each year. There are few effective treatments for either disease, and both diseases are fatal.

Researchers will study tissue samples from the NHLBI Lung Tissue Research Consortium biorepository then combine the data they generate with pathobiological, clinical and radiological data already gathered for these samples. The biorepository now contains almost 1,300 well characterized tissue samples and collects about 250 additional samples per year from patients with COPD, pulmonary fibrosis and other chronic lung diseases.

This project will be led by a team of principal investigators, including David Schwartz, MD, at National Jewish Health, Mark Geraci, MD, at the University of Colorado Denver's School of Medicine; Naftali Kaminski, MD, and Frank Sciurba, MD, at the University of Pittsburgh School of Medicine; John Quackenbush, PhD, at the Dana-Farber Cancer Institute; and Avrum Spira, MD, at Boston University School of Medicine.

SOURCE National Jewish Health


'/>"/>
SOURCE National Jewish Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information
2. Medical Travel Company Satori World Medical Announces Relationship with Managing General Underwriter GreenWood International Insurance Services (GWI)
3. Sogo Photographs for a Cause Founder Wins Place in International Exhibition
4. National Changing Diabetes Program Members Issue Statement Regarding New Federal Medical Research Grants
5. Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care
6. Retailers, NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity
7. Study: Raises and Turnover Lower in Tennessee and Florida Than National Averages
8. National Report Shines Light on Lupus 50-Year Treatment Drought
9. Park Meadows Cosmetic Surgery, a Leader in Breast Reconstruction Surgery, Recognizes National Breast Cancer Awareness Month
10. University Hospitals Case Medical Center earns prestigious national award for excellence
11. Capital BlueCross Invites National Association Leader Karen Ignagni to Discuss Status of Health Care Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
(Date:6/20/2017)... ... June 20, 2017 , ... United Benefit Advisors ... annual “UBBIE” Awards (pronounced you-bee) for 2017. The award honors Partner Firms, ... involvement with UBA, the clients they serve, and the benefits insurance industry as ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... curriculum , is pleased to announce a new online course entitled Personal ... provides practical insights and evidence-based strategies for achieving optimal well-being and teaches students ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Fresenius Vascular Care, ... minimally invasive techniques to treat and manage a wide range of vascular conditions, has ... initiative. With more than 65 centers represented by more than 40 local brands, a ...
(Date:6/20/2017)... ... 2017 , ... EdChoice and the American Enterprise Institute each ... economic development in economically distressed urban areas. The first report presents a case ... the economic development of the city of Santa Ana, California. The second report ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... Datascope Corp. is voluntarily performing a worldwide field correction of ... test failure code.     ... PART NUMBER ... 0998-UC-0446HXX; 0998-UC-0479HXX 0998-00-3013-XX;  0998-UC-3013-XX ... This field correction also applies to ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, Inc. ... today announced that the U.S. Food and Drug Administration (FDA) ... 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter ... manufacturing facility is a measure of the progress we have ...
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 More ... a further effort to help spread lessons learned from ... the International Diabetes Federation (IDF) and Eli Lilly and ... for the second phase of the Bringing Research in ... reaffirming their commitment to helping people with diabetes effectively ...
Breaking Medicine Technology: